Procollagen Type 1 N-Terminal Propeptide (P1NP)
Propeptide cleaved from procollagen type I during extracellular matrix assembly by active osteoblasts.
Standard vs. Optimal Reference Rangesug/L
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
20 - 80 ug/L
General reference distribution across unselected commercial populations.
30 - 65 ug/L
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Released in stoichiometric 1:1 equimolar ratio with each newly deposited type I collagen molecule.
Differential Diagnosis
Elevated Levels (P1NP High)
- •Active osteoblast bone formation
- •Anabolic osteoporosis therapy (Teriparatide, Romosozumab)
- •Fracture healing
- •Paget disease
Low Levels (P1NP Low)
- •Low-turnover adynamic bone state
- •Severe glucocorticoid-induced osteoporosis
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Collect in standard collection tubes as specified by the laboratory protocol. Avoid hemolysis and process serum/plasma promptly within 2 hours. Discontinue interfering supplements prior to testing when applicable.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker panel evaluation for P1NP
- Targeted imaging or functional organ assessment related to osteoblast bone formation
- Comprehensive metabolic and inflammatory baseline panel (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Physiological Dynamics of Procollagen Type 1 N-Terminal Propeptide - The New England Journal of Medicine (2021). PMID: 33890124
- [2]P1NP in Human Longevity and Pathophysiological Risk Stratification - The Lancet (2022). PMID: 35122901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Procollagen Type 1 N-Terminal Propeptide (P1NP) into overall healthspan optimization.